-
Merck
-
Trenton, New Jersey
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Rahway, New Jersey
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Trenton, New Jersey
...
in Oncology, authoring regulatory documents (investigational new drugs/INDs, clinical study reports ... clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration. Directors are
...
-
Merck
-
Rahway, New Jersey
...
in Oncology, authoring regulatory documents (investigational new drugs/INDs, clinical study reports ... clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration. Directors are
...
-
Merck
-
Little Rock, Arkansas
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Washington, District Of Columbia
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Saint Paul, Minnesota
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Austin, Texas
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Upper Gwynedd, Pennsylvania
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Madison, Wisconsin
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Dover, Delaware
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Montgomery, Alabama
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Oklahoma City, Oklahoma
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Juneau, Alaska
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Denver, Colorado
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Raleigh, North Carolina
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Springfield, Illinois
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Jackson, Mississippi
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Santa Fe, New Mexico
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Pierre, South Dakota
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Salt Lake City, Utah
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Columbia, South Carolina
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Boise, Idaho
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Nashville, Tennessee
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Honolulu, Hawaii
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Tallahassee, Florida
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Charleston, West Virginia
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Columbus, Ohio
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Olympia, Washington
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...
-
Merck
-
Jefferson City, Missouri
...
related to clinical pharmacology and pharmacometrics of oncology drugs from post-PCC to registration ... :**
Serving as an expert representative for QP2-IO on Oncology clinical development teams.
Framing
...